De novo production of K-α1 tubulin-specific antibodies: Role in chronic lung allograft rejection

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4487-4494

  Goers, Trudie A ^a,b   Ramachandran, Sabarinathan ^a,b   Aloush, Aviva ^a   Trulock, Elbert ^a   Patterson, G Alexander ^a   Mohanakumar, Thalachallour ^a,b  

^a Department of Surgery ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANTIGEN; FIBROGENIC GROWTH FACTOR; GROWTH FACTOR; HEAT SHOCK PROTEIN; LEUKOCYTE ANTIGEN; PHOSPHOKINASE C; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TCF5; TUBULIN K ALPHA1; UNCLASSIFIED DRUG; AUTOANTIBODY; FIBROBLAST GROWTH FACTOR; TUBULIN;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL SPECIFICITY; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LUNG ALVEOLUS EPITHELIUM; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; WESTERN BLOTTING; ALLOTRANSPLANTATION; CELL LINE; CHRONIC DISEASE; CLASSIFICATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GRAFT REJECTION; IMMUNOLOGY; KINETICS; METABOLISM; MIDDLE AGED; SYNDROME;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; BRONCHIOLITIS OBLITERANS; CELL LINE; CHRONIC DISEASE; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; KINETICS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SYNDROME; TRANSCRIPTION FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUBULIN;

EID: 44449177653     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4487     Document Type: Article

References (48)

1. Reinsmoen, N. L., R. M. Bolman, K. Savik, K. Butters, and M. I. Hertz. 1993. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation 55: 1040-1044.
2. Al-Githmi, I., N. Batawil, N. Shigemura, M. Hsin, T. W. Lee, G. W. He, and A. Yim. 2006. Bronchiolitis obliterans following lung transplantation. Eur. J. Cardiothorac. Surg. 30: 846-851.
3. Qu, N., A. de Haan, M. C. Harmsen, F. G. Kroese, L. F. de Leij, and J. Prop. 2003. Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for oblterative airway disease. Transplantation 76: 1022-1028.
4. Reznik, S. I., A. Jaramillo, L. Zhang, G. A. Patterson, J. D. Cooper, and T. Mohanakumar. 2000. Anti-HLA antibody binding to HLA class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome. J. Thorac. Cardiovasc. Surg. 119: 39-45.
5. Zissel, G., M. Ernst, K. Rabe, T. Papadopoulos, H. Magnussen, M. Schlaak, and J. Muller-Quernheim. 2000. Human alveolar epithelial cells type II are capable of regulating T-cell activity. J. Investig. Med. 48: 66-75.
6. Mauck, K. A., and J. D. Hosenpud. 1996. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J. Heart Lung Transplant. 15: 709-714.
7. Jaramillo, A., C. R. Smith, L. Zhang, G. A. Patterson, and T. Mohanakumar. 2003. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum. Immunol. 64: 521-529.
8. Langenbach, S. Y., L. Zheng, T. McWilliams, B. Levvey, B. Orsida, M. Bailey, T. J. Williams, and G. I. Snell. 2005. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 24: 1550 -1556.
9. Aris, R. M., S. Walsh, W. Chalermskulrat, V. Hathwar, and I. P. Neuringer. 2002. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am. J. Respir. Crit. Care Med. 166: 417-422.
10. Jaramillo, A., M. A. Smith, D. Phelan, R. S. Sundaresan, E. P. Trulock, J. P. Lynch, J. D. Cooper, G. A. Patterson, and T. Mohanakumar. 1999. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 67: 1155-1161.
11. Sundaresan, S., T. Mohanakumar, M. A. Smith, E. P. Trulock, J. Lynch, D. Phelan, J. D. Cooper, and G. A. Patterson. 1998. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65:648-653.
12. Di Filippo, S., A. Girnita, S. A. Webber, S. Tsao, G. J. Boyle, S. A. Miller, S. K. Gandhi, and A. Zeevi. 2005. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum. Immunol. 66: 513-518.
13. Dubel, L., O. Farges, C. Johanet, M. Sebagh, and H. Bismuth. 1998. Highinci-dence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 65: 1072-1075.
14. Dragun, D., D. N. Muller, J. H. Brasen, L. Fritsche, M. Nieminen-Kelha, R. Dechend, U. Kintscher, B. Rudolph, J. Hoebeke, D. Eckert, et al. 2005. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 352: 558-569.
15. Behr, T. M. 1999. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J. Heart Lung Transplant. 18: 904-912.
16. Cooper, J. D., M. Billingham, T. Egan, M. I. Hertz, T. Higenbottam, J. Lynch, J. Mauer, I. Paradis, G. A. Patterson, and C. Smith. 1993. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Translanta-tion. J. Heart Lung Transplant. 12: 713-716.
17. Iniotaki-Theodoraki, A. 2001. The role of HLA class I and class II antibodies in renal transplantation. Nephrol. Dial. Transplant. 16 (Suppl. 6): 150-152.
18. Sumitran, S. 2000. Clinical importance of HLA-specific and non-HLA-specific antibodies in allogeneic kidney transplantation. Adv. Nephrol. Necker Hosp. 30:29-39.
19. Collins, A. B., E. E. Schneeberger, M. A. Pascual, S. L. Saidman, W. W. Williams, N. Tolkoff-Rubin, A. B. Cosimi, and R. B. Colvin. 1999. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J. Am. Soc. Nephrol. 10:2208-2214.
20. Sijpkens, Y. W., S. A. Joosten, M. C. Wong, F. W. Dekker, H. Benediktsson, I. M. Bajema, J. A. Bruijn, and L. C. Paul. 2004. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int. 65:2409-2418.
21. Hadjiliadis, D., C. Chaparro, N. L. Reinsmoen, C. Gutierrez, L. G. Singer, M. P. Steele, T. K. Waddell, R. D. Davis, M. A. Hutcheon, S. M. Palmer, and S. Keshavjee. 2005. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a mul-ticenter study. J. Heart Lung Transplant. 24: S249 -254.
22. McKenna, R. M., S. K. Takemoto, and P. I. Terasaki. 2000. Anti-HLA antibodies after solid organ transplantation. Transplantation 69: 319 -326.
23. Schulman, L. L., E. K. Ho, E. F. Reed, C. McGregor, C. R. Smith, E. A. Rose, and N. M. Suciu-Foca. 1996. Immunologic monitoring in lung allograft recipients. Transplantation 61: 252-257.
24. Scornik, J. C., D. S. Zander, M. A. Baz, W. H. Donnelly, and E. D. Staples. 1999. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation 68: 1542-1546.
25. Schulman, L. L., E. Ho, E. F. Reed, C. McGregor, C. R. Smith, E. A. Rose, and N. M. Suciu-Foca. 1996. Immunologic monitoring in lung allograft recipients. Transplantation 61: 252-257.
26. Diujvestijn, A. M., J. G. Derhaag, and P. J. van Breda Vriesman. 2000. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti-non-MHC al-loantibodies are effective in complement activation. Transpl. Int. 13: 363-371.
27. Derhaag, J. G., A. M. Duijvestijn, J. G. Damoiseaux, and P. J. van Breda Vriesman. 2000. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Transplantation 69: 1899-1906.
28. Behr, T. M., H. E. Feucht, K. Richter, C. Reiter, C. H. Spes, D. Pongratz, P. Uberfuhr, B. Meiser, K. Theisen, and C. E. Angermann. 1999. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J. Heart Lung Transplant. 18: 904-912.
29. Jaramillo, A., B. Naziruddin, L. Zhang, S. I. Reznik, M. A. Smith, A. A. Aloush, E. P. Trulock, G. A. Patterson, and T. Mohanakumar. 2001. Activation ofhuman airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 71: 966 -976.
30. Carter, V., B. K. Shenton, B. Jaques, D. Turner, D. Talbot, A. Gupta, C. E. Chapman, C. J. Matthews, and G. Cavanagh. 2005. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant. Proc. 37: 654-657.
31. Rose, M. L. 2001. Anti-vimentin antibodies are an independent predictor of trans-plant-associated coronary artery disease following cardiac transplantation. Ital. Heart J. 2(Suppl. 3): 23S-25S.
32. Wilkes, D. S. 2003. The role of autoimmunity in the pathogenesis of lung allograft rejection. Arch. Immunol. Ther. Exp. 51: 227-230.
33. Fedoseyeva, E. V., F. Zhang, P. L. Orr, D. Levin, H. J. Buncke, and G. Benichou. 1999. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J. Immunol. 162: 6836-6842.
34. Benichou, G., A. Alessandrini, R. S. Charrad, and D. S. Wilkes. 2007. Induction of autoimmunity after allotransplantation. Front. Biosci. 12: 4362-4369.
35. + regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am. J. Transplant. 6: 1799-1808.
36. Smith, J. D., S. J. Crisp, M. J. Dunn, A. Pomerance, M. H. Yacoub, and M. L. Rose. 1995. Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation. Transpl. Immunol. 3: 68 -73.
37. Harmer, A. W., D. Haskard, C. G. Koffman, and K. I. Welsh. 1990. Novel antibodies associated with unexplained loss of renal allografts. Transpl. Int. 3:66-69.
38. Al-Hussein, K. A., D. Talbot, G. Proud, R. M. R. Taylor, and B. K. Shenton. 1995. The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl. Int. 8: 214-220.
39. Ferry, B. L., K. I. Welsh, M. J. Dunn, D. Law, J. Proctor, H. Chapel, M. H. Yacoub, and M. L. Rose. 1997. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl. Immunol. 5: 17-24.
40. Suberbielle Boissel, C., D. Mirebeau, C. Legendre, M. Kssentini, H. Kreis, D. Charron, and C. Raffoux. 1998. Target antigens of post-rejection non-HLA antibodies in renal transplantation. Transplant. Proc. 30: 2853.
41. Jaramillo, A., M. A. Smith, D. Phelan, S. Sundaresan, E. Trulock, J. Lynch, J. Cooper, G. A. Patterson, and T. Mohanakumar. 1999. Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant. Proc. 31:185-186.
42. Meyer, K. C., A. L. Cardoni, Z. Ziang, R. D. Cornwell, and R. B. Love. 2001. Vascular endothelial growth factor in human lung transplantation. Chest 119:137-143.
43. Krebs, R., J. M. Tikkanen, A. I. Nykanen, J. Wood, M. Jeltsch, S. Yia-Herttuala, P. K. Koskinen, and K. B. Lemstrom. 2005. Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. Am. J. Respir. Crit. Care Med. 171: 1421-1429.
44. Poli, V., F. P. Mancini, and R. Cortese. 1990. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63: 643-653.
45. Raymond, L., S. Eck, J. Mollmark, E. Hays, I. Tomek, S. Kantor, S. Elliott, and M. Vincenti. 2006. Interleukin-1β induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-β. J. Cell. Physiol. 207: 683-688.
46. Attard, F. A., L. Wang, J. J. Potter, L. Rennie-Tankersley, and E. Mezey. 2000. CCAAT/enhancer binding protein β mediates the activation of the murine α1(I) collagen promoter by acetaldehyde. Arch. Biochem. Biophys. 378: 57-64.
47. Rao, S., F. Aberg, E. Nieves, S. Band Horwitz, and G. A. Orr. 2001. Identification by mass spectrometry of a new alpha-tubulin isotype expressed in human breast and lung carcinoma cell lines. Biochemistry 40: 2096 -2103.
48. Hein, S., T. Scheffold, and J. Schaper. 1995. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J. Thorac. Cardiovasc. Surg. 110: 89-98.